291 related articles for article (PubMed ID: 8554227)
1. Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole.
Alappan R; Perazella MA; Buller GK
Ann Intern Med; 1996 Feb; 124(3):316-20. PubMed ID: 8554227
[TBL] [Abstract][Full Text] [Related]
2. Trimethoprim-sulfamethoxazole therapy in outpatients: is hyperkalemia a significant problem?
Alappan R; Buller GK; Perazella MA
Am J Nephrol; 1999; 19(3):389-94. PubMed ID: 10393376
[TBL] [Abstract][Full Text] [Related]
3. Trimethoprim-sulfamethoxazole induces reversible hyperkalemia.
Greenberg S; Reiser IW; Chou SY; Porush JG
Ann Intern Med; 1993 Aug; 119(4):291-5. PubMed ID: 8328737
[TBL] [Abstract][Full Text] [Related]
4. Effect of standard-dose trimethoprim/sulfamethoxazole on the serum potassium concentration in elderly men.
Witt JM; Koo JM; Danielson BD
Ann Pharmacother; 1996 Apr; 30(4):347-50. PubMed ID: 8729886
[TBL] [Abstract][Full Text] [Related]
5. Trimethoprim-induced hyperkalemia: An analysis of reported cases.
Marinella MA
Gerontology; 1999; 45(4):209-12. PubMed ID: 10394078
[TBL] [Abstract][Full Text] [Related]
6. Trimethoprim-induced hyperkalemia in burn patients treated with intravenous or oral trimethoprim sulfamethoxazole for methicillin-resistant Staphylococcus aureus and other infections: nature or nurture?
Ackerman BH; Patton ML; Guilday RE; Haith LR; Stair-Buchmann M; Reigart CL
J Burn Care Res; 2013; 34(1):127-32. PubMed ID: 23292580
[TBL] [Abstract][Full Text] [Related]
7. Impact of trimethoprim on serum creatinine, sodium, and potassium concentrations in patients taking trimethoprim-sulfamethoxazole without changes in glomerular filtration rate.
Yokoyama S; Nakagawa J; Aiuchi N; Seito T; Niioka T
J Clin Pharm Ther; 2022 Sep; 47(9):1409-1417. PubMed ID: 35545234
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of hyperkalemia and serum creatinine elevation associated with different dosage levels of outpatient trimethoprim-sulfamethoxazole with and without concomitant medications.
Gentry CA; Nguyen AT
Ann Pharmacother; 2013 Dec; 47(12):1618-26. PubMed ID: 24259630
[TBL] [Abstract][Full Text] [Related]
9. Dose-Dependent Hyperkalemia Among Hospitalized, HIV-Infected Patients Receiving Sulfamethoxazole/Trimethoprim.
Caulder CR; Kocherla CS; Qureshi ZP; Magagnoli J; Bookstaver PB
Ann Pharmacother; 2020 Sep; 54(9):852-857. PubMed ID: 32106685
[No Abstract] [Full Text] [Related]
10. Hyponatremia and/or hyperkalemia in patients treated with the standard dose of trimethoprim-sulfamethoxazole.
Mori H; Kuroda Y; Imamura S; Toyoda A; Yoshida I; Kawakami M; Tabei K
Intern Med; 2003 Aug; 42(8):665-9. PubMed ID: 12924488
[TBL] [Abstract][Full Text] [Related]
11. Case report: severe hyperkalemia in a geriatric patient receiving standard doses of trimethoprim-sulfamethoxazole.
Perlmutter EP; Sweeney D; Herskovits G; Kleiner M
Am J Med Sci; 1996 Feb; 311(2):84-5. PubMed ID: 8615380
[TBL] [Abstract][Full Text] [Related]
12. Co-trimoxazole induced hyperkalemia and potassium monitoring in hospitalized patients.
Plantaz MMEA; Veldman BAJ; Esselink AC; Fleuren HWHA; Kramers C
Int J Clin Pharm; 2020 Dec; 42(6):1405-1411. PubMed ID: 33025449
[TBL] [Abstract][Full Text] [Related]
13. Trimethoprim-sulfamethoxazole: hyperkalemia is an important complication regardless of dose.
Perazella MA; Mahnensmith RL
Clin Nephrol; 1996 Sep; 46(3):187-92. PubMed ID: 8879854
[TBL] [Abstract][Full Text] [Related]
14. Trimethoprim-sulfamethoxazole and risk of sudden death among patients taking spironolactone.
Antoniou T; Hollands S; Macdonald EM; Gomes T; Mamdani MM; Juurlink DN;
CMAJ; 2015 Mar; 187(4):E138-E143. PubMed ID: 25646289
[TBL] [Abstract][Full Text] [Related]
15. Renal mechanism of trimethoprim-induced hyperkalemia.
Velázquez H; Perazella MA; Wright FS; Ellison DH
Ann Intern Med; 1993 Aug; 119(4):296-301. PubMed ID: 8328738
[TBL] [Abstract][Full Text] [Related]
16. Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study.
Antoniou T; Gomes T; Mamdani MM; Yao Z; Hellings C; Garg AX; Weir MA; Juurlink DN
BMJ; 2011 Sep; 343():d5228. PubMed ID: 21911446
[TBL] [Abstract][Full Text] [Related]
17. Effect of high-dose sulfamethoxazole/trimethoprim and glucocorticoid use on hyperkalemic event: A retrospective observational study.
Hirai T; Yamaga R; Ishikawa Y; Hanada K; Iwamoto T; Itoh T
J Infect Chemother; 2021 Nov; 27(11):1607-1613. PubMed ID: 34301486
[TBL] [Abstract][Full Text] [Related]
18. Trimethoprim is a potassium-sparing diuretic like amiloride and causes hyperkalemia in high-risk patients.
Perazella MA
Am J Ther; 1997; 4(9-10):343-8. PubMed ID: 10423629
[TBL] [Abstract][Full Text] [Related]
19. [Cotrimoxazole in bone-related infections: toxicity and clinical and economic impact].
Fíca A; Lamas C; Olivares F; Ramírez D; Soto A; Porte L; Braun S; Vlllablanca I
Rev Chilena Infectol; 2015 Dec; 32(6):609-17. PubMed ID: 26928496
[TBL] [Abstract][Full Text] [Related]
20. Renal Insufficiency in Concert with Renin-angiotensin-aldosterone Inhibition Is a Major Risk Factor for Hyperkalemia Associated with Low-dose Trimethoprim-sulfamethoxazole in Adults.
Higashioka K; Niiro H; Yoshida K; Oryoji K; Kamada K; Mizuki S; Yokota E
Intern Med; 2016; 55(5):467-71. PubMed ID: 26935365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
